Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis

BACKGROUND: Atopic dermatitis (AD) is a common chronic-relapsing inflammatory skin disease hallmarked by epidermal barrier dysfunction, increased transepidermal water loss (TEWL) and decreased skin hydration. Recent findings on the T helper 2 (Th2)-driven pathogenesis of AD have led to the developme...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrucci, Silvia, Romagnuolo, Maurizio, Maronese, Carlo Alberto, Germiniasi, Francesca, Tavecchio, Simona, Angileri, Luisa, Casazza, Giovanni, Marzano, Angelo Valerio, Genovese, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655442/
https://www.ncbi.nlm.nih.gov/pubmed/34900210
http://dx.doi.org/10.1177/20406223211058332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655442/
https://www.ncbi.nlm.nih.gov/pubmed/34900210
http://dx.doi.org/10.1177/20406223211058332

Ejemplares similares